在严重和不严重的喘中表征和抑制炎症酶反应
Jay C Horvat1, Richard Y Kim2,3, Natasha Weaver2
1University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia. Jay.Horvat@newcastle.edu.au.
Respiratory research
|December 3, 2023
概括
免疫细胞中炎症酶激活的增加在不严重和严重的喘中很常见. 用MCC950准NLRP3炎症酶为喘患者提供了潜在的通用疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 导致IL-1β释放的气道NLRP3炎症酶激活与严重的喘有关.
- 目前尚不清楚这是否特异于严重喘或在炎症类型中普遍存在.
- 在喘患者中准炎症酶激活的治疗潜力需要研究.
研究的目的:
- 调查喘患者免疫细胞中的炎症酶激活和抑制.
- 为了评估IL-1β释放在不同的喘严重程度的炎症刺激的反应.
- 为了评估NLRP3抑制剂MCC950.0.3的疗效.
主要方法:
- 从健康个体和患有轻度和重度喘的患者中收集了周围血液单核细胞 (PBMC).
- 用尼日里辛,LPS或两者都刺激了PBMC,有或没有MCC950.
- 测量IL-1β释放以评估炎症酶激活和抑制.
主要成果:
- 与健康对照组相比,喘患者 (不重症和重症) 在尼日里辛刺激后IL-1β释放量增加.
- 严重喘患者的IL-1β释放高于LPS/尼格里辛联合刺激.
- 在所有刺激条件和患者群体中,MCC950有效抑制了IL-1β释放.
- 炎症酶激活与气道中毒素和中毒素的数量相关.
结论:
- 炎细胞原始/激活的增加是系统性免疫细胞在轻度和重度喘中的共同特征.
- 这些发现表明,炎症酶抑制是各种喘亚型的潜在通用治疗策略.
- 准NLRP3炎症酶通路可能为喘提供一种新的治疗方法.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
451
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
451
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K


